title: Expression of transforming growth factor-beta1 and tumour necrosis factor-alpha in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin.
abstract: OBJECTIVE
  We previously observed increased expression of interleukin-1beta, platelet-derived growth factor-A, and insulin-like growth factor-I in bronchoalveolar lavage (BAL) cells during the development of pulmonary fibrosis after an intraperitoneal administration of bleomycin in mice. The purpose of this study was to investigate the roles of tumour necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta1 in this model.
  
  
  METHODS
  We investigated the mRNA expression levels of TNF-alpha and TGF-beta1 in BAL cells of Institute for Cancer Research mice after 10 days of the intraperitoneal administration of bleomycin with or without treatment with a specific neutrophil elastase inhibitor, ONO-5046 x Na.
  
  
  RESULTS
  On day 1 but not on days 15 and 29, the relative amount of TGF-beta1 mRNA in the bleomycin-treated mice was significantly decreased compared with control mice. In the mice treated with both bleomycin and ONO-5046 x Na intermediate values for TGF-beta1 were obtained. No significant differences in TNF-alpha expression were observed in any of the treatment groups.
  
  
  CONCLUSIONS
  These results suggest that a reduced expression of TGF-beta1 in BAL cells in the early phase may be important during the development of murine pulmonary fibrosis induced by an intraperitoneal administration of bleomycin.
authors.affiliation: The Second Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Maeda
authors.forename: S
authors.initials: S
authors.lastname: Ishioka
authors.forename: Y
authors.initials: Y
authors.lastname: Taooka
authors.forename: K
authors.initials: K
authors.lastname: Hiyama
authors.forename: M
authors.initials: M
authors.lastname: Yamakido
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis; D001761:Bleomycin; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry* / Q000166:cytology; D004195:Disease Models, Animal; D007274:Injections, Intraperitoneal; D051379:Mice; D011336:Probability; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric; D016212:Transforming Growth Factor beta / Q000032:analysis*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
chemical_list: D015415:Biomarkers; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D001761:Bleomycin